Related Experiment Video
Updated: Aug 16, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Hypercholesterolaemia: simvastatin and pravastatin alter cholesterol metabolism by different mechanisms
Insights
Simvastatin effectively lowers LDL cholesterol and alters LDL composition, enhancing its ability to regulate cholesterol synthesis in cells. Pravastatin lowers LDL cholesterol but lacks these additional beneficial effects.
Area of Science:
- Biochemistry
- Pharmacology
- Cardiovascular Medicine
Background:
- Hypercholesterolemia is a major risk factor for cardiovascular disease.
- Statins are widely used to lower low-density-lipoprotein (LDL) cholesterol.
- Understanding the detailed effects of statins on LDL composition and cellular cholesterol metabolism is crucial.
Purpose of the Study:
- To compare the effects of simvastatin and pravastatin on LDL cholesterol levels.
- To investigate the impact of these drugs on LDL composition, specifically the esterified/free cholesterol ratio.
- To assess the influence of simvastatin and pravastatin on cholesterol synthesis regulation in mononuclear leucocytes.
Main Methods:
- Administered simvastatin and pravastatin to hypercholesterolemic patients.
- Measured changes in LDL cholesterol levels.
- Analyzed LDL particle composition (esterified/free cholesterol ratio).
- Assessed [14C]acetate incorporation into cholesterol in mononuclear leucocytes to evaluate cholesterol synthesis.
- Measured acyl-coenzyme A: cholesterol acyltransferase (ACAT) activity.
Main Results:
- Simvastatin reduced LDL cholesterol by 40% and significantly decreased the LDL esterified/free cholesterol ratio.
- Simvastatin treatment increased the capacity of LDL to suppress cholesterol synthesis in mononuclear leucocytes.
- [14C]acetate incorporation into leucocytes was significantly lower after simvastatin treatment.
- Pravastatin also reduced LDL cholesterol but did not alter LDL composition or cellular cholesterol metabolism as observed with simvastatin.
- ACAT activity remained unchanged with both treatments.
Conclusions:
- Both simvastatin and pravastatin are effective in lowering LDL cholesterol.
- Simvastatin exhibits additional beneficial effects beyond LDL reduction, including favorable changes in LDL composition.
- These compositional changes induced by simvastatin enhance its regulatory role in mononuclear leucocyte cholesterologenesis, suggesting a potentially broader therapeutic benefit.
Abstract:
The 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor simvastatin, reduced low-density-lipoprotein (LDL) cholesterol in hypercholesterolaemic patients by 40% (P less than 0.001). The reduction in LDL cholesterol was accompanied by a significant decrease in the esterified/free cholesterol ratio of the patients' LDL from 2.51 +/- 0.13 to 2.06 +/- 0.14 (P less than 0.01). This change led to a significant increase (P less than 0.05) in the capacity of the LDL to suppress [14C]acetate incorporation into cholesterol in mononuclear leucocytes. Furthermore, [14C]acetate incorporation into the patients mononuclear leucocytes was significantly lower (P less than 0.02) following drug treatment (117 +/- 22 vs. 162 +/- 29 nmol/mg cell protein). Comparison of simvastatin with another HMG-CoA reductase inhibitor pravastatin, showed similar reduction in LDL cholesterol. Pravastatin treatment however, did not result in a reduction in the LDL esterified/free cholesterol ratio or in the changes in cellular cholesterol synthesis and its regulation by LDL which accompanied simvastatin treatment. The activity of the enzyme acyl-coenzyme A: cholesterol acyltransferase (ACAT) in patients' mononuclear cells remained unchanged after treatment with either drug. Results of the study show that while the drugs are equally effective in lowering LDL cholesterol, simvastatin has additional compositional effects on LDL which increase its capacity to regulate mononuclear leucocyte cholesterologenesis.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Hepatic Drug Clearance: Effect of Protein Binding
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion, mediated...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

